Practice Management platform Unified Women’s Healthcare, today announced that it has acquired Women’s Health USA, a practice management services provider for the women’s health sector. Sverica Capital Management, the current majority shareholder in WHUSA, has reinvested a portion of its proceeds into the combined company. Unified is backed by a leading practice management platform in women’s healthcare backed by Altas Partners, funds…
BioReference Laboratories, an OPKO Health company, has announced the acquisition of the U.S. Ariosa centralized laboratory prenatal testing business from Roche. Ariosa’s non invasive prenatal screening (NIPS) test, the Harmony Prenatal Test, is one of the most widely studied tests utilized in prenatal screening. The test has been performed in over 1.5 million patients. GenPath, BioReference’s specialty health division, currently offers, ClariTest Core, which utilizes the same…
Labcorp, a leading global life sciences company has acquired Ovia Health, a digital health platform dedicated to family planning, pregnancy and parenting. Labcorp supports OB-GYNs and primary care doctors by providing essential testing, screening, educational support and clinical trial options for women including expectant mothers. This creates a better understanding of a patient’s health and potential risks and enables that patient to…
PLBY Group, the owner of Playboy, one of the most iconic brands in the world, has acquired Australia-based Honey Birdette, a fast-growing, luxury lingerie and lifestyle brand. PLBY Group serves consumers in four major categories: Sexual Wellness, Style & Apparel, Gaming & Lifestyle, and Beauty & Grooming. Honey Birdette sells carefully detailed lingerie and high-end toys for the bedroom. Ben Kohn, Chief…
Owlet, a company building a connected and accessible nursery ecosystem that brings technology and vital data to modern parenting, today announced that it has completed its business combination with Sandbridge Acquisition Corporation, a special purpose acquisition company. The business combination and concurrent private placement, which were approved by Sandbridge’s stockholders at its special meeting held on July 14, 2021, provide over $135…
Organon, a global women’s healthcare company, today announced the completion of its acquisition of Alydia Health, a commercial-stage medical device company focused on preventing maternal morbidity and mortality caused by postpartum hemorrhage (PPH) or abnormal postpartum uterine bleeding. Postpartum hemorrhage is one of the most common complications of birth, requiring pharmacologic treatment in up to 10% of mothers and potentially resulting in…
Healthtech company Ro today announced the acquisition of femtech company Modern Fertility, a high-growth reproductive health company focused on addressing gaps in women’s healthcare through fertility testing, research, education, and community. Since 2017, Modern Fertility has empowered people with ovaries nationwide to play a more active role in their health and build the lives they want on their own terms. The acquisition represents…
Femasys, a biomedical company focused on women’s health, has reportedly filed for a $40.25M IPO and will list on the Nasdaq under the ticker “FEMY”. We are a biomedical company focused on transforming women’s healthcare by developing novel solutions and next-generation advancements providing significant clinical impact to address severely underserved areas. Our mission is to provide women worldwide with superior minimally-invasive, non-surgical product…
